Clinical trial
A Randomized Comparison of the Supralimus® Stent With the Xience V™ Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions
NCT00917163 is registered in ClinicalTrials.gov with Sahajanand Medical Technologies Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Comparison of the Supralimus® Stent With the Xience V™ Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions
- Lead sponsor
- Sahajanand Medical Technologies Limited
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2009
- Completion date
- May 31, 2010
- Enrollment
- 13 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.